Tag Archives: SRPT

Hot Medical Stocks To Own Right Now

Insulet (NASDAQ: PODD) is one of 106 publicly-traded companies in the “Surgical & medical instruments” industry, but how does it weigh in compared to its peers? We will compare Insulet to related companies based on the strength of its valuation, earnings, analyst recommendations, institutional ownership, risk, dividends and profitability.

Volatility & Risk


Top 5 High Tech Stocks To Watch Right Now

The February stock market rout created a tremendous opportunity for long-term investors. Everyone is asking which stocks make sense for the rest of 2018 and beyond. The following five stocks are my favorite large-cap names for a buy-and-hold portfolio.

1. United Parcel Service (NYSE: UPS)
Shares of this package delivery service have plunged around 30% from their January 2018 highs. The....More>>>

Top 10 Performing Stocks For 2019

On Friday, four out of ten of the worst performing small cap stocks had double digit losses due to announcing public stock offerings:

Medical device stock Transenterix Inc (NYSEMKT: TRXC) sank 40.37% after announcing a $24.9 million offeringand the pricing of its public offering of units, each consisting of one share of the Companys common stock, one Series A warrant to purchase one share....More>>>

Top 5 Value Stocks To Own For 2018

Apple, already the world’s largest company by market cap, looks likely to become even bigger. Its recent gains put it on track to hit a never-before-seen target, one technician says.

“This is the breakout move that is going to take this stock to be the first $1 trillion market-cap company, in my opinion,” Craig Johnson, chief market technician at Piper Jaffray, told CNBC’s....More>>>

Top 10 Safest Stocks To Invest In Right Now

Conventional wisdom suggests that investors should find safe stocks to buy. Penny stocks and potential “triple-baggers” might be more exciting and a big win might provide a better story, but experts will tell you the smart play is to benefit from compounding returns in safe, stable stocks.

That general strategy is similar to that followed by Warren Buffett with Berkshire Hathaway....More>>>

Top 5 Blue Chip Stocks To Buy For 2018


Dont take any stated yields for granted these days! The financial news has been flooded with dividend cuts lately, with Teva Pharmaceutical (TEVA) and Mattel (MAT) taking the hatchet to their payouts, and telecom Windstream (WIN) dropping its dividend too.

Its dangerous to buy headline yields or even supposedly safe blue chips with more modest dividends without looking....More>>>

Top Biotech Stocks To Invest In 2018

Few investments have the profit potential of penny stocks, which are stocks that trade under $5 per share.

Just take a look at Marathon Patent Group Inc. (Nasdaq: MARA), which climbed an astounding 341% during the four trading days of Thanksgiving week.

Biotech penny stocks are especially attractive since successful clinical trial results for their drugs can often send their share....More>>>

Top Bank Stocks To Buy For 2019

Chairman & CEO of Comerica Inc (NYSE:CMA) Ralph W Jr Babb sold 65,300 shares of CMA on 02/02/2018 at an average price of $97.61 a share. The total sale was $6.4 million.

Comerica Inc is a financial services company. It operates in three business segments, The Business Bank, The Retail Bank, and Wealth Management. It operates in three primary geographic markets, Michigan, California and....More>>>

Sarepta Therapeutics (SRPT) Price Target Raised to $91.00 at Morgan Stanley

Sarepta Therapeutics (NASDAQ:SRPT) had its target price increased by Morgan Stanley from $87.00 to $91.00 in a report issued on Friday. Morgan Stanley currently has an equal weight rating on the biotechnology company’s stock.

Other equities research analysts also recently issued research reports about the company. BidaskClub upgraded Sarepta Therapeutics from a hold rating to a buy....More>>>

Sarepta Therapeutics: Backing A Cure For Duchenne Muscular Dystrophy

Succeeding 13 years of R&D with a commercial-level rare disease drug, Sarepta Therapeutics, Inc. (NASDAQ:SRPT) tees up to deliver on the latter half of its promise to provide the world with a DMD cure for sufferers that may be amenable to Exon 51 skipping, and otherwise. A result that would facilitate the first cure for DMD and sizable growth potential.

In 2016, Sarepta Therapeutics,....More>>>